Plasminogen activator inhibitor type 1 (PAI-1) level and activity at patients with PAI-1 polymorphism

被引：0
|
作者：
Shelest, A. [1 ]
Matveeva, M. A. [1 ]
Popova, L., V [1 ]
Patrushev, L., I [2 ]
Shuganov, E. G. [1 ]
Gneusheva, T. Y. [1 ]
Bokarev, I. N. [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ MSMU, Moscow, Russia
[2] Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1173 / 1173
页数：1
相关论文
共 50 条
  • [1] Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin - Characterization of different PAI-1 mutants
    De Prada, NA
    Schroeck, F
    Sinner, EK
    Muehlenweg, B
    Twellmeyer, J
    Sperl, S
    Wilhelm, OG
    Schmitt, M
    Magdolen, V
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (01): : 184 - 192
  • [2] Do plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator PAI-1 complexes (tPA-PAI-1) Predict complications in type 1 diabetes (TID)?
    Bosnyak, Z
    Forrest, KYZ
    Maser, RE
    Orchard, TJ
    [J]. DIABETES, 2001, 50 : A209 - A209
  • [3] STABILIZATION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) ACTIVITY BY ARGININE - POSSIBLE IMPLICATIONS FOR THE INTERACTION OF PAI-1 WITH VITRONECTIN
    KEIJER, J
    LINDERS, M
    EHRLICH, H
    GEBBINK, RK
    PANNEKOEK, H
    [J]. FIBRINOLYSIS, 1990, 4 (03) : 153 - 159
  • [4] Effect of troglitazone on plasminogen activator inhibitor on (PAI-1)
    Fonseca, V
    Reynolds, T
    Hemphill, D
    Randolph, C
    Valiquett, T
    Graveline, J
    Fink, L
    [J]. DIABETOLOGIA, 1997, 40 : 1616 - 1616
  • [5] Thrombolysis failure: A role for plasminogen activator inhibitor type 1 (PAI-1)
    Nicholls, SC
    Chandler, WL
    Hoffer, EK
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) : 559 - 560
  • [6] Mechanistic studies on the inactivation of plasminogen activator inhibitor 1 (PAI-1) by the small molecule PAI-1 antagonist PAI-749
    Gardell, SJ
    Antrilli, TM
    Elokdah, H
    Krueger, JA
    Mayer, S
    Orcutt, SJ
    Vlasuk, GP
    Crandall, DL
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) : E104 - E104
  • [7] Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression
    Ramon, Luis A.
    Gilabert-Estelles, Juan
    Cosin, Raul
    Gilabert, Juan
    Espana, Francisco
    Castello, Remedios
    Chirivella, Melitina
    Romeu, Alberto
    Estelles, Amparo
    [J]. THROMBOSIS RESEARCH, 2008, 122 (06) : 854 - 860
  • [8] Plasminogen activator inhibitor-1 (PAI-1) 4G5G polymorphism and PAI-1 enzyme activity in young patients with ischemic stroke
    Santos, M. S.
    Sabino, A. P.
    Carvalho, M. G.
    Ribeiro, D. D.
    Gadelha, T.
    Dusse, L. S.
    Fernandes, A. P.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 431 - 431
  • [9] The international standard for plasminogen activator inhibitor-1 (PAI-1) activity
    Gaffney, PJ
    Edgell, TA
    [J]. THROMBOSIS AND HAEMOSTASIS, 1996, 76 (01) : 80 - 83
  • [10] Clearance of tissue plasminogen activator (TPA) and TPA plasminogen activator inhibitor type 1 (PAI-1) complex - Relationship to elevated TPA antigen in patients with high PAI-1 activity levels
    Chandler, WL
    Alessi, MC
    Aillaud, MF
    Henderson, P
    Vague, P
    JuhanVague, I
    [J]. CIRCULATION, 1997, 96 (03) : 761 - 768
12345